EC Paediatrics

Case Report Volume 8 Issue 6 - 2019

Drug Hypersensitivity: Stevens Johnson Syndrome in a Teenage Patient

Maria Fernanda Rocha1, Maria Lucia Macias Frias1, Sabrina Soledad Bonifacio2, Fabian Mazzitelli3, Mariano Tomas Masci4, Claudia Migazzi5, Fernanda Viturro6, Adriana Romani7, Christian Oscar Mosca8,9*

1Residents of Dentistry, Hospital Interzonal General de Agudos, President Perón, Avellaneda, Buenos Aires, Argentina
2Post-teaching Teaching Assistantship, Hospital Interzonal General de Agudos, President Perón, Avellaneda, Buenos Aires, Argentina
3Head of the Room, Medical Clinic, Hospital Interzonal General de Agudos, President Perón, Avellaneda, Buenos Aires, Argentina
4Resident of Infectiology, Hospital Interzonal General de Agudos, President Perón, Avellaneda, Buenos Aires, Argentina
5Infectious Disease Service Plant Medica, Hospital Interzonal General de Agudos, President Perón, Avellaneda, Buenos Aires, Argentina
6Concurrent of the Infectious Disease Service, Hospital Interzonal General de Agudos, President Perón, Avellaneda, Buenos Aires, Argentina 7Chief of Infectology, Hospital Interzonal General de Agudos, President Perón, Avellaneda, Buenos Aires, Argentina
8Teacher Collaborator Advisor, Hospital Interzonal General de Agudos, President Perón, Avellaneda, Buenos Aires, Argentina
9Professor of the Specialty of Surgery and Traumatology Bucomaxillofacial, Faculty of Dentistry of the National University of the Northeast, Corrientes, Argentina

*Corresponding Author: Christian Oscar Mosca, Teacher Collaborator Advisor, Hospital Interzonal General de Agudos, President Perón, Avellaneda, Buenos Aires, Argentina.
Received: May 03, 2019; Published: May 29, 2019

The Stevens Johnson Syndrome (SJS) is one of the most severe skin diseases, with a high morbidity and mortality. It is part of a spectrum of reactional dermatitis and is distinguished by the extent of affected skin.

The majority of cases are the result of a hypersensitivity reaction to viruses, fungi, bacteria, infections, malignancies, or the ingestion of some medication, the latter being the most common cause.

In the present article we present the case of a male patient of 23 years of age who attends the medical clinic service of the General Interzonal Hospital of Acute President Perón de Avellaneda, presenting a hypersensitivity reaction associated with antiepileptic medication, compatible with Stevens Syndrome Johnson.

Keywords: Steven Johnson Syndrome; Hypersensitivity; Medications

  1. Sylvia Aide Martínez-Cabriales., et al. “Actualidades en farmacodermias severas: síndrome de Stevens-Johnson (SSJ) y necrólisis epi- dérmica tóxica (NET)”. Gaceta Medica de Mexico 6 (2015): 777-787.
  2. Edwards IR and Aronson “Adverse drug reactions: definitions, diagnosis, and management”. Lancet 356.9237 (2000): 1255-1259.
  3. Palencia , et al. “Dimenhidrato como causa de síndrome de Stevens Johnson”. Acta Médica Colombiana 41.1 (2016): 96.
  4. Assier H., et al. “Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes”. Archives of Dermatology 5 (1995): 539-543.
  5. Mockenhaupt M and Schopf “Epidemiology of drug-induced severe skin reactions”. Seminars in Cutaneous Medicine and Surgery 15.4 (1996): 236-243.
  6. Lin , et al. “Severe cutaneous adverse reactions related to systemic antibiotics”. Clinical Infectious Diseases 58.10 (2014): 1377-1385.
  7. Claudia Andrea Hernández., et al. “Síndrome de Stevens-Johnson y necrólisis epidérmica tóxica”. Revista de la Asociación Colombiana de Dermatología and Cirugía Dermatológica 19 (2011): 67-75.
  8. Mockenhaupt “Severe drug-induced skin reactions: Clinical pattern, diagnostics and therapy”. JDDG: Journal der Deutschen Derma- tologischen Gesellschaft 7.2 (2009): 142-160.
  9. French “Toxic epidermal necrolysis and Stevens-Johnson syndrome: Our current understanding”. Allergology International 55.1 (2006): 9-16.
  10. Bastuji-Garin , et al. “Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multi- forme”. Archives of Dermatology 129.1 (1993): 92-96.
  11. Stevens , et al. “Mycoplasma pneumoniae infections in children”. Archives of Disease in Childhood 53.1 (1978): 38-42.
  12. Fournier , et al. “Toxic epidermal necrolysis associated with Mycoplasma pneumoniae infection”. European Journal of Clinical Micro- biology and Infectious Diseases 14.6 (1995): 558-559.
  13. Halevy S., et al. “Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel”. Journal of the American Academy of Dermatology 1(2008): 25-32.
  14. Barbaud , et al. “A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cuta- neous adverse drug reactions”. British Journal of Dermatology 168.3 (2013): 555-562.
  15. Knowels S., et al. “Anticonvulsivant hypersensitivity syndrome: Incidence, prevention and management”. Drug Safety 6 (1999): 489-501.
  16. Nogueiras Álvarez R. “Nogueiras Álvarez Revisión del síndrome de hipersensibilidad a anticonvulsivantes, a propósito de un caso clínico complejo”. Medicina Clínica Práctica (2019).
  17. Garcia-Doval , et al. “Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?” Archives of Dermatology 136.3 (2000): 323-327.
  18. Harr T and French “Toxic epidermal necrolysis and Stevens-Johnson syndrome”. Orphanet Journal of Rare Diseases 5 (2010): 39.
  19. Harr T and French “Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome”. Medical Clinics of North America 94.4 (2010): 727-742.
  20. Ghislain PD and Roujeau “Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hyper- sensitivity syndrome”. Dermatology Online Journal 8.1 (2002): 5.
  21. Schulz , et al. “A 10-year experience with toxic epidermal necrolysis”. Journal of Burn Care and Rehabilitation 21.3 (2000): 199-204.
  22. Van der Meer JB., et al. “Successful dexamethasone pulse therapy in a toxic epidermal necrolysis (TEN) patient featuring recurrent TEN to oxazepam”. Clinical and Experimental Dermatology 8 (2001): 654.
  23. Tripathi A., et al. “Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: A total series of 67 cases”. Allergy and Asthma Proceedings 2 (2000): 101-105.
  24. Roujeau “Treatment of severe drug eruptions”. The Journal of Dermatology 26.11 (1999): 718-722.
  25. Heng MC and Allen “Efficacy of cyclophosphamide in toxic epidermal necrolysis. Clinical and pathophysiologic aspects”. Journal of the American Academy of Dermatology 25.5-1 (1991): 778-786.
  26. Sakellariou , et al. “Plasma exchange (PE) treatment in drug-induced toxic epidermal necrolysis (TEN)”. The International Journal of Artificial Organs 14.10 (1991): 634-638.
  27. Chaidemenos , et al. “Plasmapheresis in toxic epidermal necrolysis”. International Journal of Dermatology 36.3 (1997): 218-221.
  28. Kostal , et al. “Beneficial effect of plasma exchange in the treatment of toxic epidermal necrolysis: a series of four cases”. Journal of Clinical Apheresis 27.4 (2012): 215-220.
  29. Worsnop , et al. “Reaction to biological drugs: infliximab for the treatment of toxic epidermal necrolysis subsequently triggering erosive lichen planus”. Clinical and Experimental Dermatology 37.8 (2012): 879-881.
  30. Napolitano , et al. “Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus successfully treated with a single dose of etanercept: report of three cases”. Journal of the American Academy of Dermatology 69.6 (2013): e303-e305.

Christian Oscar Mosca., et al. Drug Hypersensitivity: Stevens Johnson Syndrome in a Teenage Patient EC Paediatrics 8.6 (2019): 505-516.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net